Association Between Statin Use and Risk of Dementia After a Concussion

被引:39
作者
Redelmeier, Donald A. [1 ,2 ,3 ,4 ,5 ]
Manzoor, Fizza [1 ,2 ,3 ]
Thiruchelvam, Deva [3 ]
机构
[1] Univ Toronto, Dept Med, Toronto, ON, Canada
[2] Sunnybrook Res Inst, Evaluat Clin Sci Program, Toronto, ON, Canada
[3] Inst Clin Evaluat Sci Ontario, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Div Gen Internal Med, 2075 Bayview Ave,Ste G-151, Toronto, ON M4N 3M5, Canada
[5] Ctr Leading Injury Prevent Practice Educ & Res, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
TRAUMATIC BRAIN-INJURY; CHRONIC SUBDURAL-HEMATOMA; ALZHEIMER-DISEASE; VASCULAR-DISEASE; ATORVASTATIN; POPULATION; HEALTH; THERAPY; CARE; DEPRESSION;
D O I
10.1001/jamaneurol.2019.1148
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Key PointsQuestionIs statin use associated with an increased or decreased risk of subsequent dementia after a concussion? FindingsIn this large extended population-based double cohort study following 28815 patients after a concussion, the 5-year incidence of dementia was substantial and statin use was associated with a significantly reduced risk of subsequent dementia. MeaningConcussions are associated with an increased long-term risk of dementia, which is modestly reduced for patients receiving a statin. This large extended population-based double cohort study tests whether statin use is associated with an increased or decreased risk of subsequent dementia after a concussion among older adults. ImportanceConcussions are an acute injury that may lead to chronic disability, while statin use might improve neurologic recovery. ObjectiveTo test whether statin use is associated with an increased or decreased risk of subsequent dementia after a concussion. Design, Setting, and ParticipantsLarge extended population-based double cohort study in Ontario, Canada, from April 1, 1993, to April 1, 2013 (enrollment), and continued until March 31, 2016 (follow-up). Dates of analysis were April 28, 2014, through March 21, 2019. Participants were older adults diagnosed as having a concussion, excluding severe cases resulting in hospitalization, individuals with a prior diagnosis of dementia or delirium, and those who died within 90 days. ExposureStatin prescription within 90 days after a concussion. Main Outcome and MeasureLong-term incidence of dementia. ResultsThis study identified 28815 patients diagnosed as having a concussion (median age, 76 years; 61.3% female), of whom 7058 (24.5%) received a statin, and 21757 (75.5%) did not receive a statin. A total of 4727 patients subsequently developed dementia over a mean follow-up of 3.9 years, equal to an incidence of 1 case per 6 patients. Patients who received a statin had a 13% reduced risk of dementia compared with patients who did not receive a statin (relative risk, 0.87; 95% CI, 0.81-0.93; P<.001). The decreased risk of dementia associated with statin use applied to diverse patient groups, remained independent of other cardiovascular medication use, intensified over time, was distinct from the risk of subsequent depression, and was not observed in patients after an ankle sprain. Conclusions and RelevanceIn this study, older adults had a substantial long-term risk of dementia after a concussion, which was associated with a modest reduction among patients receiving a statin.
引用
收藏
页码:887 / 896
页数:10
相关论文
共 123 条
  • [11] Physical Activity Interventions in Preventing Cognitive Decline and Alzheimer-Type Dementia A Systematic Review
    Brasure, Michelle
    Desai, Priyanka
    Davila, Heather
    Nelson, Victoria A.
    Calvert, Collin
    Jutkowitz, Eric
    Butler, Mary
    Fink, Howard A.
    Ratner, Edward
    Hemmy, Laura S.
    McCarten, J. Riley
    Barclay, Terry R.
    Kane, Robert L.
    [J]. ANNALS OF INTERNAL MEDICINE, 2018, 168 (01) : 30 - +
  • [12] Bronskill S., 2011, Health System Use by Frail Ontario Seniors: An In-Depth Examination of Four Vulnerable Cohorts
  • [13] Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect
    Brookhart, M. Alan
    Patrick, Amanda R.
    Dormuth, Colin
    Avorn, Jerry
    Shrank, William
    Cadarette, Suzanne M.
    Solomon, Daniel H.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 166 (03) : 348 - 354
  • [14] Cholesterol-independent neuroprotective and neurotoxic activities of statins: Perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders
    Butterfield, D. Allan
    Barone, Eugenio
    Mancuso, Cesare
    [J]. PHARMACOLOGICAL RESEARCH, 2011, 64 (03) : 180 - 186
  • [15] Canadian Institute for Health Information, 2008, CIHI DAT QUAL STUD E
  • [16] Carlsson CM, 2012, CURR ALZHEIMER RES, V9, P990
  • [17] Are We Underestimating the Burden of Traumatic Brain Injury? Surveillance of Severe Traumatic Brain Injury Using Centers for Disease Control International Classification of Disease, Ninth Revision, Clinical Modification, Traumatic Brain Injury Codes
    Carroll, Christopher P.
    Cochran, Joseph A.
    Guse, Clare E.
    Wang, Marjorie C.
    [J]. NEUROSURGERY, 2012, 71 (06) : 1064 - 1070
  • [18] Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300
  • [19] The use of atorvastatin for chronic subdural haematoma: a retrospective cohort comparison study
    Chan, David Yuen Chung
    Chan, Danny Tat Ming
    Sun, Tin Fung David
    Ng, Stephanie Chi Ping
    Wong, George Kwok Chu
    Poon, Wai Sang
    [J]. BRITISH JOURNAL OF NEUROSURGERY, 2017, 31 (01) : 72 - 77
  • [20] Inhibition of the integrated stress response reverses cognitive deficits after traumatic brain injury
    Chou, Austin
    Krukowski, Karen
    Jopson, Timothy
    Zhu, Ping Jun
    Costa-Mattioli, Mauro
    Walter, Peter
    Rosi, Susanna
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (31) : E6420 - E6426